| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |